Kwang Woo Ahn, PhD
Division of Biostatistics
Institute for Health & Society
Education: PhD The University of Iowa 2008
Dr. Kwang Woo Ahn is an Assistant Professor in the Division of Biostatistics at the Medical College of Wisconsin. He joined the division in the fall of 2008. He has been collaborating with various research groups at MCW including Center for International Blood & Marrow Transplant Research (CIBMTR), Department of Physiology, Department of Neurosurgery and Neurology, and Department of Plastic Surgery. In CIBMTR, he is serving as PhD statistician of several working committees including Chronic Leukemia, Infection and Immune Reconstitution, Solid Tumor, and Autoimmune Diseases working committees. He is involved in projects on hypertension, next generation sequencing data, and brain injury from Physiology, Neurosurgery, and Plastic Surgery. His current research interest includes nonlinear time series analysis, survival analysis, and Bayesian statistics.
Ahn KW, Chan KS, Bai Y, and Kosoy M. Bayesian inference with incomplete multinomial data: A problem in pathogen diversity. Journal of the American Statistical Association. 105 (490) 600-611, 2010.
Ahn KW and Chan KS. Efficient Markov chain Monte Carlo with incomplete multinomial data. Statistics and Computing, 20 (4) 447-456, 2010.
Ahn KW and Chan KS. On the convergence rate of the unscented transformation. Annals of the Institute of Statistical Mathematics. 65: 889-912, 2013.
Ahn KW and Chan KS. On approximate conditional least squares estimation of a nonlinear state-space model via unscented Kalman filter. Computational Statistics & Data Analysis. in press.
Copelan EA, Hamilton BK, Avalos B, Ahn KW, Bolwell BJ, Zhu X, Aljurf M, van Besien K, Bredeson CN, Cahn JY, Costa LJ, de Lima M, Gale RP, Hale GA, Halter J, Hamadani M, Inamoto Y, Kamble RT, Litzow MR, Loren AW, Marks DI, Olavarria E, Roy V, Sabloff M, Savani BN, Seftel M, Schouten HC, Ustun C, Waller EK, Weisdorf DJ, Wirk B, Horowitz MM, Arora M, Szer J, Cortes J, Kalaycio ME, Maziarz RT, Saber W. Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared to TBI. Blood. 2013 Sep 24. [Epub ahead of print]